Organization

Heron Therapeutics

11 clinical trials

Clinical trial
A Phase 4, Open-Label Safety Study of Repeat Doses of SUSTOL in Adult Subjects Receiving Chemotherapy
Status: Active (not recruiting), Estimated PCD: 2025-10-01
Clinical trial
A Phase 2, Two-Part, Multicenter Study of HTX-011 in Spinal Surgery
Status: Completed, Estimated PCD: 2022-07-29